Mesoblast taps investors for $60.5m to underpin new research
MELBOURNE: Mesoblast has convinced long-suffering shareholders to plough an extra $US40m ($60.5m) into the stem
MELBOURNE: Mesoblast has convinced long-suffering shareholders to plough an extra $US40m ($60.5m) into the stem